• BridgeBio Pharma (BBIO) Moves 15.1% Higher: Will This Strength Last? Yahoo Finance Fri, 10 Jul 2026 09:33:00 GMT
• BridgeBio Pharma Inc. (BBIO) Stock Price | Live Quotes & Charts | NASDAQ timothysykes.com Thu, 09 Jul 2026 22:59:51 GMT
• Form 144 BRIDGEBIO PHARMA For: 9 July By Investing.com Investing.com South Africa Thu, 09 Jul 2026 21:10:50 GMT
• BridgeBio Pharma BBIO Jumps As Infigratinib Data, $1B Raise Fire Up Bulls timothysykes.com Thu, 09 Jul 2026 21:04:00 GMT
• BridgeBio stock jumps after rival heart drug fails key trial thestreet.com Thu, 09 Jul 2026 20:38:00 GMT
• Why AstraZeneca Crashed 6%, Leading Two Rivals, Including Pfizer, To Jump Investor's Business Daily Thu, 09 Jul 2026 20:26:00 GMT
• U.S. Markets Closed Up Thursday; BridgeBio Pharma Led Increases Barron's Thu, 09 Jul 2026 20:11:00 GMT
• BridgeBio Pharma BBIO Jumps On Trial Win And $1B Raise StocksToTrade Thu, 09 Jul 2026 20:03:00 GMT
• BBIO Stock Climbs As Infigratinib Data And $1B Raise Energize Bulls timothysykes.com Thu, 09 Jul 2026 18:33:00 GMT
• BridgeBio hits 52-week high on late-stage trial setback for Astra/ Ionis (update) Seeking Alpha Thu, 09 Jul 2026 16:29:00 GMT
• Alnylam, BridgeBio Gain From AstraZeneca-Ionis Drug Missing Target -- Market Talk Moomoo Thu, 09 Jul 2026 16:24:42 GMT
• Pfizer, Alnylam, BridgeBio gain after late-stage trial setback for Astra/Ionis MSN Thu, 09 Jul 2026 15:33:45 GMT
• BBIO Stock Climbs As $1B Raise Fuels Infigratinib Momentum timothysykes.com Thu, 09 Jul 2026 15:32:00 GMT
• BridgeBio Pharma Jumps as Investors React to Fresh Acoramidis Data and New Capital Quiver Quantitative Thu, 09 Jul 2026 14:50:00 GMT
• BridgeBio Pharma stock reaches all-time high at 86.0 USD Investing.com Thu, 09 Jul 2026 14:33:03 GMT
• BridgeBio Pharma Up Over 14%, on Track for Record High Close -- Data Talk Moomoo Thu, 09 Jul 2026 14:11:00 GMT
• BBIO Stock Climbs As Trial Win And $1B Raise Reset Outlook StocksToTrade Thu, 09 Jul 2026 14:03:00 GMT
• BridgeBio Pharma (BBIO) Is Up 5.1% After Kidney Data Boost Attruby And Infigratinib Advances simplywall.st Thu, 09 Jul 2026 13:32:04 GMT
• BridgeBio Pharma (BBIO) and Alnylam Pharma (ALNY) Surge After As GuruFocus Thu, 09 Jul 2026 12:27:45 GMT
• AstraZeneca, Ionis drug fails big heart disease study in major setback BioPharma Dive Thu, 09 Jul 2026 12:17:37 GMT
• Is BridgeBio Pharma (BBIO) Trading At A Premium Already? Yahoo Finance Thu, 09 Jul 2026 12:12:40 GMT
• S&P 500 Futures Climb in Premarket Trading; Alnylam Pharmaceuticals, BridgeBio Pharma Lead Barron's Thu, 09 Jul 2026 11:30:00 GMT
• pfizer, alnylam, bridgebio gain on astra/ ionis setback (pfe:nyse) Seeking Alpha Thu, 09 Jul 2026 11:26:09 GMT
• Why is BridgeBio Pharma stock surging today? By Investing.com Investing.com India Thu, 09 Jul 2026 11:24:51 GMT
• Alnylam, BridgeBio shares surge as rival’s heart drug fails late-stage trial Investing.com Nigeria Thu, 09 Jul 2026 10:07:26 GMT
• The Future of Biotech? BridgeBio, Ionis and BioMarin Are Worth Watching Technology Org Thu, 09 Jul 2026 06:51:18 GMT
• BridgeBio seesaws after settlement in Pfizer Vyndamax patent dispute (update) MSN Wed, 08 Jul 2026 20:56:05 GMT
• Is BBIO Stock a Buy Now or Too Expensive for the Risk Ahead Yahoo Finance Wed, 08 Jul 2026 16:25:00 GMT
• BridgeBio Stock Taps Rare Disease Trends and New Diagnosis Growth Zacks Investment Research Wed, 08 Jul 2026 15:30:57 GMT
• BridgeBio Stock Outlook Hinges on Attruby & New Drug Catalysts Zacks Investment Research Wed, 08 Jul 2026 15:30:57 GMT
• BridgeBio Pharma Stock On Fire: Up 14% With 9-Day Winning Streak Trefis Wed, 08 Jul 2026 12:26:53 GMT
• bridgebio pharma reportedly in talks for $1b preferred equity from kkr, sixth street MSN Wed, 08 Jul 2026 11:39:43 GMT
• BridgeBio (BBIO) Bank of America 2025 Healthcare Conference Summary Quartr Wed, 08 Jul 2026 07:00:00 GMT
• Epidermolysis Bullosa Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Re... Barchart.com Tue, 07 Jul 2026 22:22:23 GMT
• BridgeBio Pharma’s SWOT analysis: stock gains momentum on pipeline strength Investing.com Tue, 07 Jul 2026 14:07:55 GMT
• the future of biotech? bridgebio, ionis and biomarin are worth watching Technology Org Tue, 07 Jul 2026 06:16:46 GMT
• Jefferies Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $100 Moomoo Mon, 06 Jul 2026 13:31:00 GMT
• BridgeBio touts kidney benefits for Attruby, differentiating from amyloidosis competitors BioSpace Mon, 06 Jul 2026 12:01:24 GMT
• BridgeBio Pharma (BBIO) Stock Analysis: Uncovering a 32.5% Potential Upside for Biotech Investors DirectorsTalk Interviews Mon, 06 Jul 2026 09:21:17 GMT
• bridgebio pharma reportedly in talks for $1b preferred equity from kkr, sixth street MSN Mon, 06 Jul 2026 07:18:22 GMT
• bridgebio earnings up next: attruby growth key amid competition Investing.com Mon, 06 Jul 2026 00:32:42 GMT
• bridgebio seesaws after settlement in pfizer vyndamax patent dispute (update) MSN Sat, 04 Jul 2026 19:59:25 GMT
• bridgebio earnings up next: attruby growth key amid competition Investing.com Sat, 04 Jul 2026 12:15:56 GMT
• Price to book forward of BridgeBio Pharma, Inc. – NASDAQ:BBIO TradingView Sat, 04 Jul 2026 09:14:46 GMT
• enterprise value to revenue forward of bridgebio pharma, inc. – fwb:2cl TradingView Sat, 04 Jul 2026 08:02:21 GMT
• bbot sec filings - bridgebio oncology therapeutics, inc 10-k, 10-q, 8-k forms Stock Titan Fri, 03 Jul 2026 22:25:45 GMT
• BridgeBio secures $1 billion in convertible preferred equity By Investing.com Investing.com Nigeria Fri, 03 Jul 2026 17:11:29 GMT
• BridgeBio Pharma Raises $933.9 Million Via 7% Convertible Preferred From Sixth Street, HCRx TradingView Thu, 02 Jul 2026 20:33:33 GMT
• BridgeBio (Nasdaq: BBIO) secures $933.9M in senior convertible preferred equity Stock Titan Thu, 02 Jul 2026 20:24:10 GMT
• exclusive bac article: bridgebio pharma; attruby sales growth q1 2026, pdufa reviews encaleret & bbp-418 underway, positive ph3 in... Seeking Alpha Thu, 02 Jul 2026 17:12:20 GMT
• bridgebio reports kidney function data for acoramidis in attr-cm Investing.com Thu, 02 Jul 2026 12:12:59 GMT
• BridgeBio Pharma Announces New Circulation: Heart Failure Analyses Showing Kidney-Protective Effects of Acoramidis in ATTR-CM Quiver Quantitative Thu, 02 Jul 2026 11:40:00 GMT
• bridgebio says acoramidis showed kidney protection in attr-cm study Stock Titan Thu, 02 Jul 2026 11:30:00 GMT
• acoramidis associated with first-ever early and sustained direct kidney-protective effects in attr-cm Yahoo Finance Thu, 02 Jul 2026 11:30:00 GMT
• the future of biotech? bridgebio, ionis and biomarin are worth watching Technology Org Thu, 02 Jul 2026 06:39:04 GMT
• latham & watkins advises bridgebio on up to us$1 billion preferred equity investment, one of the largest preferred investments for... Legal Desire Media and Insights Thu, 02 Jul 2026 05:43:58 GMT
• BridgeBio Pharma Announces $1 Billion Convertible Preferred Equity Deal Moomoo Wed, 01 Jul 2026 17:51:44 GMT
• bridgebio secures $1 billion in convertible preferred equity by investing.com Investing.com South Africa Wed, 01 Jul 2026 12:33:07 GMT
• BridgeBio gets funding for drug launch; United buys into cell therapy Yahoo Finance Wed, 01 Jul 2026 11:29:00 GMT
• global private equity giants continue to increase investments in the innovative pharmaceuticals sector, with firms including kkr i... 富途牛牛 Wed, 01 Jul 2026 09:43:07 GMT
• market chatter: kkr, sixth street to invest $1 billion in bridgebio preferred equity Moomoo Wed, 01 Jul 2026 08:53:53 GMT
• BridgeBio attracts $1B in equity for new launches, but analyst smells M&A ‘dry powder’ Fierce Pharma Wed, 01 Jul 2026 07:00:00 GMT
• BridgeBio Raises $1 Billion in Preferred Equity to Accelerate Present and Upcoming Launches Yahoo Finance Wed, 01 Jul 2026 07:00:00 GMT
• BridgeBio lands $1 billion, mostly from S.F.'s Sixth Street, with three late-stage drugs in hand The Business Journals Wed, 01 Jul 2026 07:00:00 GMT
• BridgeBio gets $1B from Sixth Street, HCRx for three launches Stock Titan Wed, 01 Jul 2026 07:00:00 GMT
• bridgebio pharma reportedly in talks for $1b preferred equity from kkr, sixth street MSN Wed, 01 Jul 2026 05:48:46 GMT
• sixth street, kkr provide bridgebio $1 billion preferred equity Bloomberg.com Wed, 01 Jul 2026 01:41:00 GMT
• Why BridgeBio Pharma (BBIO) Is Up 8.5% After NEJM-Published Infigratinib Phase 3 Achondroplasia Data simplywall.st Tue, 30 Jun 2026 23:22:33 GMT
• Sixth Street, KKR Provide BridgeBio $1 Billion Preferred Equity Bloomberg.com Tue, 30 Jun 2026 07:00:00 GMT
• Is BridgeBio Oncology Therapeutics, Inc. (BBOT) Stock a Rising Oncology Opportunity With KRAS G12C Therapy Potential? Yahoo Finance Tue, 30 Jun 2026 07:00:00 GMT
• bridgebio pharma remains a buy on attruby launch and strong late-stage pipeline targeting rare diseases. Pluang Mon, 29 Jun 2026 19:12:22 GMT
• bridgebio pharma, inc.(nasdaqgs: bbio) dropped from russell 2000 index marketscreener.com Mon, 29 Jun 2026 18:52:09 GMT
• BridgeBio’s achondroplasia pill shows ‘compelling’ growth and body proportionality benefit BioSpace Mon, 29 Jun 2026 11:06:00 GMT
• BridgeBio Pharma Meets Primary Endpoint For Achondroplasia Drug in Phase 3 Trial Moomoo Mon, 29 Jun 2026 10:10:18 GMT
• bridgebio pharma, inc. (bbio): investor outlook highlights 45.61% potential upside amid robust pipeline DirectorsTalk Interviews Mon, 29 Jun 2026 09:23:15 GMT
• BridgeBio Pharma, Inc.(NasdaqGS: BBIO) added to Russell 1000 Value Benchmark marketscreener.com Mon, 29 Jun 2026 07:36:37 GMT
• BridgeBio: 3 New Drug Approvals In Sight Outweigh Attruby Issues, Still Bullish (BBIO) Seeking Alpha Mon, 29 Jun 2026 07:00:00 GMT
• bridgebio (bbio) reports positive phase 3 results for infigratin GuruFocus Mon, 29 Jun 2026 01:18:45 GMT
• bridgebio pharma, inc.(nasdaqgs: bbio) added to russell 3000 value benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• bridgebio pharma, inc.(nasdaqgs:bbio) added to russell small cap comp value benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• bridgebio pharma, inc.(nasdaqgs: bbio) dropped from russell 2000 dynamic index marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• phase 3 trial of oral infigratinib shows signif... | pluang – crypto, stocks, gold & funds Pluang Sun, 28 Jun 2026 21:27:49 GMT
• bridgebio pharma announces nejm publication and iccbh presentation of positive phase 3 propel 3 data for oral infigratinib in acho... Quiver Quantitative Sun, 28 Jun 2026 20:10:00 GMT
• BridgeBio Announces Publication in the New England Journal of Medicine of Phase 3 PROPEL 3 Trial of Oral Infigratinib in Children ... Yahoo Finance Sun, 28 Jun 2026 07:00:00 GMT
• BridgeBio Pharma, Inc. Actuals & Estimates (NASDAQ:BBIO) TradingView Sat, 27 Jun 2026 14:58:11 GMT
• bridgebio shareholders approve board changes and equity plan The Globe and Mail Sat, 27 Jun 2026 13:04:00 GMT
• BridgeBio Pharma (NASDAQ: BBIO) shareholders approve directors and add 2M plan shares Stock Titan Fri, 26 Jun 2026 07:00:00 GMT
• enterprise value to revenue forward of bridgebio pharma, inc. – ls:a2plx7 TradingView Thu, 25 Jun 2026 21:12:22 GMT
• price to book forward of bridgebio pharma, inc. – ls:a2plx7 TradingView Thu, 25 Jun 2026 19:30:43 GMT
• enterprise value to ebitda forward of bridgebio pharma, inc. – nasdaq:bbio TradingView Thu, 25 Jun 2026 14:04:25 GMT
• price to sales forward of bridgebio pharma, inc. – nasdaq:bbio TradingView Thu, 25 Jun 2026 08:58:57 GMT
• enterprise value to ebit forward of bridgebio pharma, inc. – nasdaq:bbio TradingView Thu, 25 Jun 2026 08:21:41 GMT
• price to earnings forward of bridgebio pharma, inc. – nasdaq:bbio TradingView Thu, 25 Jun 2026 07:20:53 GMT
• bridgebio pharma insider sold shares worth $2,752,270, according to a recent sec filing Moomoo Thu, 25 Jun 2026 07:00:00 GMT
• bridgebio pharma director valantine sells $341,523 in shares Investing.com UK Thu, 25 Jun 2026 02:46:42 GMT
• form 4 bridgebio pharma inc for: 24 june by investing.com Investing.com Nigeria Wed, 24 Jun 2026 22:30:35 GMT
• bridgebio (bbio) director sells 5,004 shares, receives rsu and option grants Stock Titan Wed, 24 Jun 2026 22:06:53 GMT
• bridgebio (nasdaq: bbio) director granted 3,990 rsus and 5,277 stock options Stock Titan Wed, 24 Jun 2026 22:05:59 GMT
• [form 4] bridgebio pharma, inc. insider trading activity Stock Titan Wed, 24 Jun 2026 22:05:59 GMT
• is bridgebio (bbio) one of the best upside stocks to buy according to hedge funds? Insider Monkey Wed, 24 Jun 2026 13:46:56 GMT
• bridgebio pharma inc (bbio) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 24 Jun 2026 08:03:11 GMT
• Is BridgeBio Pharma (BBIO) Undervalued As Rare Disease Launch Hopes Face A Rich P/S? simplywall.st Wed, 24 Jun 2026 07:00:00 GMT
• BridgeBio (NASDAQ: BBIO) director receives new RSU and stock option awards Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• BridgeBio Pharma (BBIO) director sells stock, exercises options and receives RSUs Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• BridgeBio Pharma director Valantine sells $341,523 in shares Investing.com Wed, 24 Jun 2026 07:00:00 GMT
• BridgeBio (BBIO) director Charles Homcy receives RSU and stock option awards Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• BridgeBio Pharma director Jennifer Cook sells $2.75m in stock. Investing.com Wed, 24 Jun 2026 07:00:00 GMT
• bridgebio pharma (bbio) director awarded rsus and stock options Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• bridgebio pharma (bbio) director granted rsus and stock options Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• bridgebio (nasdaq: bbio) awards rsus and stock options to director Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• bridgebio pharma (bbio) director fred hassan granted rsus and stock options Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• bridgebio (bbio) director mccormick awarded rsus, options and updates holdings Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• form 144 bridgebio pharma for: 23 june by investing.com Investing.com Nigeria Wed, 24 Jun 2026 03:36:22 GMT
• form 4 bridgebio pharma inc for: 23 june by investing.com Investing.com South Africa Wed, 24 Jun 2026 03:30:09 GMT
• form 4 bridgebio pharma inc for: 23 june by investing.com Investing.com Nigeria Tue, 23 Jun 2026 23:05:58 GMT
• bridgebio pharma (bbio) director has 788 shares withheld for rsu taxes Stock Titan Tue, 23 Jun 2026 22:46:43 GMT
• form 144: 90,240-share sale reported for bbio (jennifer cook) Stock Titan Tue, 23 Jun 2026 20:34:08 GMT
• morgan stanley (nasdaq: bbio) files notice to sell 2,196 shares Stock Titan Tue, 23 Jun 2026 20:02:40 GMT
• BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Yahoo Finance Tue, 23 Jun 2026 07:00:00 GMT
• BridgeBio lures 30 new employees with 66,810 share grants Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• bridgebio pharma inc (bbio) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• form 144 bridgebio pharma for: 22 june by investing.com Investing.com Nigeria Tue, 23 Jun 2026 00:03:35 GMT
• form 144 bridgebio pharma for: 22 june by investing.com Investing.com Australia Mon, 22 Jun 2026 23:31:31 GMT
• bridgebio to present positive phase 3 trial results of oral infigratinib for children with achondroplasia at iccbh 2026. Pluang Mon, 22 Jun 2026 14:38:07 GMT
• mizuho securities maintains bridgebio pharma(bbio.us) with buy rating, maintains target price $96 Moomoo Mon, 22 Jun 2026 12:31:00 GMT
• bridgebio to present achondroplasia study data at congress Investing.com Mon, 22 Jun 2026 11:55:34 GMT
• bridgebio pharma, inc. (bbio) stock analysis: exploring a 54% potential upside in biotechnology DirectorsTalk Interviews Mon, 22 Jun 2026 09:21:03 GMT
• BridgeBio Pharma to Present Additional Positive PROPEL 3 Data and Multiple Achondroplasia and ADH1 Studies at ICCBH 2026 Quiver Quantitative Mon, 22 Jun 2026 07:00:00 GMT
• bridgebio to present primary results from phase 3 propel 3 trial of oral infigratinib for children living with achondroplasia at i... Yahoo Finance Mon, 22 Jun 2026 07:00:00 GMT
• what bridgebio pharma (bbio)'s new phase 3 infigratinib data reveal about its rare disease strategy simplywall.st Mon, 22 Jun 2026 07:00:00 GMT
• united states transthyretin amyloid cardiomyopathy (attr-cm) openPR.com Fri, 19 Jun 2026 09:49:34 GMT
• bridgebio pharma stock slides 1.66% amid push for faster drug development, bridgebio pharma warns Traders Union Fri, 19 Jun 2026 07:19:09 GMT
BridgeBio Pharma, Inc(NASDAQ:BBIO) 
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs inc...
Website: http://www.bridgebio.com
Founded: 2015
IPO Price: $17 (Jun 27, 2019)
Full Time Employees: 369
CEO: Neil Kumar
Sector: Healthcare
Industry: Biotechnology